stars 1 stars 2 stars 3

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group operates 15 manufacturing sites and 5 R&D centers in Europe, North America and Asia. 2,700 employees contribute to the success of SEQENS, among which 300 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

SEQENS Questions

The SEQENS annual revenue was $1.1 billion in 2026.

Ludovic Lyonnet is the Managing Director of SEQENS.

922 people are employed at SEQENS.

SEQENS is based in Écully, Auvergne-Rhône-Alpes.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users